Home Protein Tyrosine Kinase IGF-1R inhibitor NVP-AEW541 For research use only.

NVP-AEW541

Synonyms: AEW541

NVP-AEW541 is a potent inhibitor of IGF-1R/InsR with IC50 of 150 nM/140 nM in cell-free assays, greater potency and selectivity for IGF-1R in a cell-based assay.

NVP-AEW541 Chemical Structure

NVP-AEW541 Chemical Structure

CAS: 475489-16-8

Selleck's NVP-AEW541 has been cited by 64 publications

Purity & Quality Control

Batch: Purity: 99.61%
99.61

NVP-AEW541 Related Products

Signaling Pathway

IGF-1R Signaling Pathways

IGF-1R Signaling Pathway

Choose Selective IGF-1R Inhibitors

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
NWT-21 Kinase assay ~10 μM DMSO inhibits IGF-IR with IC50 of 0.086 ± 0.028 μM 15050915
A14 Kinase assay ~10 μM DMSO inhibits InsR with IC50 of 2.3 ± 0.163 μM 15050915
A431  Kinase assay ~10 μM DMSO inhibits HER1 with IC50 of >10 μM 15050915
A31  Kinase assay ~10 μM DMSO inhibits PDGFR with IC50 of >10 μM 15050915
GIST882 Kinase assay ~10 μM DMSO inhibits c-Kit with IC50 of >5 μM 15050915
32D-Bcr-Abl Kinase assay ~10 μM DMSO inhibits Bcr-Abl p210 with IC50 of >10 μM 15050915
MCF-7  Cytoxicity assay DMSO IC50=1.64 μM 15050915
NWT-21 Growth inhibitory assay DMSO IC50=0.163 μM 15050915
TC-71 Growth inhibitory assay ~1 μM DMSO inhibits insulin-like growth factor-I–mediated growth 15867386
TC-71 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
Saos-2 Growth inhibitory assay ~7 μM DMSO IC50<3 μM 15867386
U-2OS Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
SK-ES-1 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
SK-N-MC Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
RD-ES Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
SJ-Rh 30 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
SJ-Rh 4 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
6647 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
SARG Growth inhibitory assay ~7 μM DMSO IC50<3 μM 15867386
MOS Growth inhibitory assay ~7 μM DMSO IC50<4 μM 15867386
IOR/OS7 Growth inhibitory assay ~7 μM DMSO IC50<1 μM 15867386
IOR/OS9 Growth inhibitory assay ~7 μM DMSO IC50<6 μM 15867386
IOR/OS10 Growth inhibitory assay ~7 μM DMSO IC50<5 μM 15867386
IOR/OS14 Growth inhibitory assay ~7 μM DMSO IC50<4 μM 15867386
LAP35 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
IOR/BRZ Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
IOR/CAR Growth inhibitory assay ~7 μM DMSO IC50<1 μM 15867386
IOR/NGR Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
IOR/RCH Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
RMZ-RC2 Growth inhibitory assay ~7 μM DMSO IC50<0.5 μM 15867386
CCA Growth inhibitory assay ~7 μM DMSO IC50<2 μM 15867386
RD/18 Growth inhibitory assay ~7 μM DMSO IC50<4 μM 15867386
OVCAR-3 Growth inhibitory assay ~15 μM DMSO inhibits cell proliferation 16300820
OVCAR-4 Growth inhibitory assay ~15 μM DMSO inhibits cell proliferation 16300820
OVCAR-3 Apoptosis assay ~15 μM DMSO induces apoptosis 16300820
OVCAR-4 Apoptosis assay ~15 μM DMSO induces apoptosis 16300820
OVCAR-3 Function assay ~15 μM DMSO Decreases phosphorylation of AKT 16300820
Huh-7 Growth inhibitory assay ~10 μM DMSO IC50=1.4 μM 16530734
Hep-G2 Growth inhibitory assay ~10 μM DMSO IC50=1.8 μM 16530734
Hep-3B Growth inhibitory assay ~10 μM DMSO IC50=1.9 μM 16530734
SK-Hep-1 Growth inhibitory assay ~10 μM DMSO IC50=6.9 μM 16530734
Huh-7 Function assay ~10 μM DMSO Induces cell cycle arrest 16530734
Hep-G2 Function assay ~10 μM DMSO Induces cell cycle arrest 16530734
SK-Hep-1 Function assay ~10 μM DMSO Induces cell cycle arrest 16530734
BON Kinase assay ~6 μM DMSO induces dephosphorylation of IGF-1R 16601284
BON Growth inhibitory assay ~10 μM DMSO IC50=6.6 μM 16601284
CM Growth inhibitory assay ~5 μM DMSO IC50=3.3 μM 16601284
BON Function assay ~7.5 μM DMSO induces cell cycle arrest 16601284
CM Function assay ~5 μM DMSO induces cell cycle arrest 16601284
BON Apoptosis assay ~7.5 μM DMSO induces Apoptosis 16601284
CM Apoptosis assay ~5 μM DMSO induces Apoptosis 16601284
HT-29 Growth inhibitory assay ~10 μM DMSO IC50=1.7 μM 17007015
HCT-116 Growth inhibitory assay ~10 μM DMSO IC50=2.5 μM 17007015
primary colorectal cancer cells Function assay ~5 μM DMSO alters the morphology of the remaining cells 17007015
HTLA-230 Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
KCNR Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
SK-N-BE2c Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
SK-N-BE Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
LAN-5 Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
GI-CA-N Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
SH-EP Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
SK-N-AS Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
RN-GA Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
SY-5Y(N) Function assay ~8 μM DMSO inhibits IGF-II-mediated stimulation of IGF-IR and Akt 17121898
GI-CA-N Growth inhibitory assay ~8 μM DMSO IC50= 6.8 μM 17121898
SH-EP Growth inhibitory assay ~8 μM DMSO IC50= 3 μM 17121898
HTLA-230 Growth inhibitory assay ~8 μM DMSO IC50= 0.5 μM 17121898
SK-N-BE2c Growth inhibitory assay ~8 μM DMSO IC50= 1.1 μM 17121898
SK-N-BE2 Growth inhibitory assay ~8 μM DMSO IC50= 3 μM 17121898
SY-5Y (N) Growth inhibitory assay ~8 μM DMSO IC50= 2.4 μM 17121898
LAN-5 Growth inhibitory assay ~8 μM DMSO IC50= 0.4 μM 17121898
KCNR Growth inhibitory assay ~8 μM DMSO IC50= 0.4 μM 17121898
RN-GA Growth inhibitory assay ~8 μM DMSO IC50= 1.3 μM 17121898
SK-N-AS Growth inhibitory assay ~8 μM DMSO induces apoptosis 17121898
KCNR Apoptosis assay ~8 μM DMSO induces apoptosis 17121898
GI-CA-N Apoptosis assay ~8 μM DMSO induces apoptosis 17121898
HTLA-230 Apoptosis assay ~8 μM DMSO induces apoptosis 17121898
SK-N-BE2c Apoptosis assay ~8 μM DMSO induces apoptosis 17121898
SY-5Y (N) Apoptosis assay ~8 μM DMSO induces apoptosis 17121898
HL60AR Function assay 160 nM enhances the levels of p27Kip1 17361225
HL60AR Apoptosis assay ~200 nM induces apoptosis 17361225
HPAF-II Kinase assay ~1 μM DMSO inhibits IGF-I-mediated signalling 18445520
HPAF-II Growth inhibitory assay ~2 μM DMSO inhibits cell proliferation 18445520
HPAF-II Function assay ~2 μM DMSO inhibits basal and IGF-I-mediated pancreatic cancer cell migration 18445520
TFK-1 Growth inhibitory assay ~250 nM DMSO IC50=0.26 μM 20066734
EGI-1 Growth inhibitory assay ~250 nM DMSO IC50=0.28 μM 20066734
CC-LP-1 Growth inhibitory assay ~250 nM DMSO IC50=0.15 μM 20066734
CC-SW-1 Growth inhibitory assay ~250 nM DMSO IC50=0.54 μM 20066734
Sk-ChA-1 Growth inhibitory assay ~250 nM DMSO IC50=0.2 μM 20066734
Mz-ChA-1 Growth inhibitory assay ~250 nM DMSO IC50=1.39 μM 20066734
Mz-ChA-2 Growth inhibitory assay ~250 nM DMSO IC50=0.73 μM 20066734
ECC-1 Kinase assay ~10 μM DMSO inhibits IGF-IR activation by 98% 21295335
Ishikawa Kinase assay ~10 μM DMSO inhibits IGF-IR activation by 93% 21295335
USPC-1 Kinase assay ~10 μM DMSO inhibits IGF-IR activation by 100% 21295335
USPC-2 Kinase assay ~10 μM DMSO inhibits IGF-IR activation by 96% 21295335
ECC-1 Growth inhibitory assay ~10 μM DMSO decreases cell proliferation 21295335
Ishikawa Growth inhibitory assay ~10 μM DMSO decreases cell proliferation 21295335
USPC-1 Growth inhibitory assay ~10 μM DMSO decreases cell proliferation 21295335
USPC-2 Growth inhibitory assay ~10 μM DMSO decreases cell proliferation 21295335
Ba/F3 Function assay Inhibition of full length IGF-1 receptor (unknown origin) transfected in Ba/F3 cells assessed as cell proliferation, IC50=0.02μM 26951753
HEK293 Function assay 60 mins Inhibition of full length IGF-1 receptor (unknown origin) autophosphorylation transfected in HEK293 cells pretreated for 60 mins followed by IGF-1 stimulation measured after 10 mins by quantitative Western blot analysis, IC50=0.065μM 26951753
HEK293 Function assay Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 cells, IC50=0.13μM 26951753
Ba/F3 Function assay Inhibition of full length insulin receptor (unknown origin) transfected in Ba/F3 cells assessed as cell proliferation, IC50=0.244μM 26951753
HEK293 Function assay 60 mins Inhibition of full length insulin receptor (unknown origin) autophosphorylation transfected in HEK293 cells pretreated for 60 mins followed by IGF-1 stimulation measured after 10 mins by quantitative Western blot analysis, IC50=0.892μM 26951753
TC32 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells 29435139
NB-EBc1 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells 29435139
Saos-2 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells 29435139
LAN-5 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells 29435139
OHS-50 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells 29435139
RD qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells 29435139
Rh41 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells 29435139
Click to View More Cell Line Experimental Data

Biological Activity

Description NVP-AEW541 is a potent inhibitor of IGF-1R/InsR with IC50 of 150 nM/140 nM in cell-free assays, greater potency and selectivity for IGF-1R in a cell-based assay.
Targets
Insulin Receptor [1]
(Cell-free assay)		 IGF-1R [1]
(Cell-free assay)		 FLT3 [1]
(Cell-free assay)		 Tek [1]
(Cell-free assay)		 FLT1 [1]
(Cell-free assay)		 Click to View More Targets
0.14 μM 0.15 μM 0.42 μM 0.53 μM 0.6 μM
In vitro
In vitro NVP-AEW541 also inhibits InsR, Tek, Flt1 and Flt3 with IC50 of 140 nM, 530 nM, 600 nM and 420 nM in purified kinases/recombinant kinase domains assay. NVP-AEW541 is more selective and shows 27-fold more potent than InsR at the cellular level. NVP-AEW541 suppresses the IGF-I-mediated survival, soft agar and proliferation of MCF-7 cells with IC50 of 0.162 μM, 0.105 μM and 1.64 μM, respectively. NVP-AEW541 also reduces the level of phospho-IGF-1R and phospho-PKB in NWT-21 cells. [1] NVP-AEW541 shows growth inhibitory effect on TC-71 musculoskeletal sarcoma cells in low-serum medium as well as in 10% FBS–containing medium. NVP-AEW541 inhibits cell cycle progression and induces specific G1 arrest in sarcoma cell lines (TC-71, SK-N-MC, SaoS-2, RD/18 and RH4). [2] NVP-AEW541 could inhibit the growth of human neuroblastoma cells with IC50 of 0.4-6.8 μM. An increase in the hypodiploid fraction and the depletion of the S and G2-M compartments could be detected in these cell lines. NVP-AEW541-driven inhibition of IGF-1R causes a reduction of phosphorylation of Akt, but not of Erk1 and Erk2 in neuroblastoma cells. [3] NVP-AEW541 inhibits glioma cell growth and disrupts the autocrine loop initiated by HIF1α stabilization. [4] A recent study shows that NVP-AEW541 suppresses the proliferation and viability of PC3, DU145, and 22Rv1 prostate cancer cells, without necessarity of associated cell death. NVP-AEW541 decreases phospho-Akt levels in 22Rv1 and DU415 cells but not PC3 cells, without affecting total Akt levels, which shows that PTEN status could determine the effectiveness of NVP-AEW541 with essential Akt. NVP-AEW541-induced radiosensization is dependent on Akt activation status. NVP-AEW541 could increase the H2AX phosphorylation (a measure of DSBs) in PC3, DU145, and 22Rv1 cells. [5]
Kinase Assay In vitro kinase assays
NVP-AEW541 is dissolved in DMSO (10 mM) and stored at -20 °C. Dilutions are freshly made in DMSO/water 1:1. The final concentration of DMSO in the enzyme assays is <0.5 %. The protein kinase assays are carried out in 96-well plates at RT and terminated by the addition of 20 μL of 125 mM EDTA. Subsequently, 30 μL (c-Abl, c-Src, IGF-1R) of the reaction mixture are transferred onto Immobilon-PVDF presoaked for 5 min with methanol, rinsed with water, then soaked for 5 min with 0.5 % H3PO4 and mounted on vacuum manifold. After spotting all samples, vacuum is connected and each well rinsed with 200 μL 0.5 % H3PO4. Membranes are removed and washed 4× on a shaker with 1.0 % H3PO4, once with ethanol. After drying, mounting in Packard TopCount 96-well frame, and adding of 10 μL/well of Microscint, membranes are counted. IC50 values are calculated by linear regression analysis of the percentage inhibition of NVP-AEW541 in duplicate, at four concentrations (usually 0.01, 0.1, 1, and 10 μM). One unit of protein kinase activity is defined as 1 nmol of 33P transferred from [γ33P]ATP to the substrate protein per minute per mg of protein at 37 °C.
Cell Research Cell lines MCF-7 cells
Concentrations ~ 10 μM
Incubation Time 72 hours
Method Between 3 × 103 and 6 × 103 cells/well are seeded in 96-well plates with a total media volume of 100 μL/well. Increasing concentrations of NVP-AEW541 is added 24 hours thereafter in quadruplicate. 72 hours later, cells are fixed by addition of 25 μL/well Glutaraldehyde (20%) and incubation for 10 min at RT. Cells are then washed 2× with 200 μL/well H2O and 100 μL Methylene Blue (0.05%) is added. After incubation for 10 min at RT, cells are washed 3× with 200 μL/well H2O. 200 μL/well HCl (3%) is added, and following incubation for 30 min at RT on a plate shaker, absorbance is measured at 650 nm.
In Vivo
In vivo NVP-AEW541 (50 mg/kg, p.o.) results in abrogation of basal and IGF-I-induced receptor, and PKB and MAPK phosphorylation, with T/C value of 14% in the NWT-21 tumor xenograft. [1] NVP-AEW541 (50 mg/kg) causes tumor shrinkage in both HTLA-230 and SK-N-BE2c xenografts, without signs of systemic toxicity. NVP-AEW541 could inhibit tumor invasion both in Matrigel-coated chambers and in HTLA-230 xenografts. [3]
Animal Research Animal Models Female Harlan athymic nude mice weighing 18-25 g with NWT-21 cells
Dosages 20, 30, or 50 mg/kg
Administration Administered via p.o. twice daily

Chemical Information & Solubility

Molecular Weight 439.55 Formula

C27H29N5O
CAS No. 475489-16-8 SDF Download NVP-AEW541 SDF
Smiles C1CN(C1)CC2CC(C2)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC=C5)OCC6=CC=CC=C6
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 88 mg/mL ( (200.2 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 24 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy NVP-AEW541 | NVP-AEW541 supplier | purchase NVP-AEW541 | NVP-AEW541 cost | NVP-AEW541 manufacturer | order NVP-AEW541 | NVP-AEW541 distributor